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D99676 PulmonaryandSyatamicRaaponsastoSubatsrrcaPin PatientswithHeartFailurewithandwithout
PulmonaryHypertension
P.J.Cowburn, J.D. McArthur, W.S. Hillis, J.J.V. McMurray, H.J. Dargie,
J.G.F. Cleland. Clinical Research hrititftive in Heart Fai/ure, Universifyof
Glasgow and Western lnfirma~, Glasgow, UK
There iaoonsiderable evidence that some aspects of endothelial function are
disordered in patients with chronic heart failure (CHF), but vasodilatation in
reaponse to Substance P has been repotted to be unaffected. We infused
Substance P (0.16, 0.32, 0.64 pmol/kgrmin for 5 minutes each) into the pul-
monaty artery of twelve patients with CHF. Cardiac output and pulmonary
pressures were measured using a thermodilution catheter. Systemic pres-
sures were measured using an automated sphygmomanometer. Data are
given as mean & standard deviation.
Maximum haemodynamic response were obsewed at the 0.32 or 0.64
pmol/kg/min doses.
Baaeline Peak statistics
HR 82* 17 86* 19 p= 0,06
MAP 91 *10 85• 12 p = 0.02
RAP 7*4 7*5 ns
MPAP 30* 13 29* t2 ns
PCWP 19+8 18+8 ns
c1 2.2 +0.7 2.5 +0.6 p <0.0001
SVR 1750+440 1395 + 312 p <0001
PVR 257* 180 212 + 145 p <0,01
Six patients had a mean pulmonary artery.pressure (MPAP) >30 mmHg.
Only in these patientadid Substance Preduce pulmona~ vaacularresistance
and in these patients Substance P also appeared to induce a greater fall in
SVR. These data suggest that the vasodilator response to Substance P
persists in patients with heati failure and in those patients with pulmonary
hypertension the res~nse maybe enhanced.
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D99738 AecendingAortaAtharosclarosisisa RaliableMarkarfor CoronaryArteryDiseasein Advanced
Age Patiants
J. Barbataasa, C. Pitaavos, C. Aggeli, A. Frogoudaki, T. Paarros,
P.Toutouzaa. Cardiac DepaRrnent, UniversifyofAthens, Greece
Thorscicaortaatheroaeleroais (TAA)has baanshownto predict the existence
of obstructive coronary artery disease (CAD). To assess if this holds true in
advanced aged patients (pts) also, we studied 109 pts (mean age 69 * 5,
range 60-60 yra) by multilane transesophageal echoesrdiography (TEE)
for the evaluation of TAA compared to angiogrsphically documented CAD.
Of the pts examined, 52 were referred for valvular, 32 for CAD and 25 for
other cardiac causes. TAA was diagnosed by increaaed echodensity of the
intima with well-defined atheroma protruding in the aortic lumen.
Results: 47/109 (43%) had CAD and 62/109 pts had normal coronary
arteriea. TAA was obsemd on TEE in 75/109 (69Yo)pts, of whom 46 (61Yo)
had CAD, while only 1/34 pta without TAA had CAD. TEE detected localized
TAAin 14pta, IOhadatheromasonly inthedescending aorta and40nlyinthe
aortic arch, one of them had CAD. Twenty-nine pts had diffuse TAA involving
the descending aorta and the aortic arch, 17 of these had CAD. Thirty-two
pta had diffuse TAA with a%ending aorta involvement (29 in combination
with the aortic arch and the descending aorta, 3 in combination with the
descending aorta), 28 of them had CAD.
PredictionofCAD se Sp PPV NPV DA
A 2% 79% 7% 52% 46%
36% Sl% 59% 63”/0 61%
: 60% 94% 60% 75% 79%
D 9s% 53% 61% 97% 72%
A= localizedTAA, B=diffuse TAA withouteacendingaorta involvement,C =dii7uaeTM
withsaeendingaorta involvement,D = exiatence of TAA, Se = sensitivity,Sp = specificity,
PPV = positivepredictivevalue, NPV = negative predictivevalue, DA = diagnosticaccu-
raoy
It is concluded that in advanced age patients: 1) Localized TAA is not a
predictor for CAD: 2) Diffuse TAA, espaeially whan tha ascending aorta is
involved has the best predictive value (88%) for CAD. 3) The absence of TAA
is highly predictive for normal corona~ arteries.
1997-391 Aga-RalatadAorti~ StiffaningCorrelataswith
Diastolic Function
M.J. Malkowski, W. Rogers, D. Coast, C.M. Kramer, S. Dianzumba,
R, Pyeritz, N. Reichek, A//egheny University of the Hea/th Sciences,
Pittsburgh, PA, USA
Diastolic dysfunefion is an important cause of heart failure in the elderly.
However, the effect of age-related changes in aortic funefion on diastolic
function is not well defined. We studied 6 young (Y) (age =25+3 years) and
6 elderly (E) (age = 73 + 4 years) normal subjects by transthoracic echo-
cardiography to assess the relationship between diastolic filling pro~rties
and elastic properties of the aorta. Aortic systolic (ASD) and diastolic (ADD)
diameter were measured from M-mode, 3 cm above the aortic valve and
elastic modulus (EM) was calculated (pulse pressure/ADD-ASD x ADD). LV
diameter, posterfor wall thickness and septal thickness were meaaured and
LV mass index (LVMI)and fractional shortening (FS) were calculated. laovo-
Iumic relaxation time (IVRT)and peak E/peak A ratio (WA) were measured by
Doppler.The two groups were compared by unpaired atudent t-teat. Systolic
function by FS was normal in both groups (0.35 + 0.07 vs. 0,36 & 0.06; E
vs. Y,P = NS).
LVMI (g/mz) EIA iVRT (msec) EM (106dyneWcm2)
‘i 62& 6 1.6 + 0.3 76& 7 0.6 + 0.3
E 60& 12 0.9 l 0.2 116+ 17 1.9 * 0,9
P 0.04 o,cao2 0.0005 0.007
Despite a greater pulse pressure (66+7 vs. 39+ 12 mmHg; E vs. Y, p
= 0.006), the change in aortic diameter was similar (1.7 + 0.9 vs. 2.3+ 0.7
mm; E vs. Y, p = NS) reflecting deereased aortic compliance in the elderly
group. By linear regression, EM strongly correlated with IVRT (~ =0.63), HA
(p =0.56) and age (# = 0.55) but not with LVMI.Age-related stiffening of the
aorta ia strongly related to changes in diastolic filling and may contribute to
the increased incidence of heari failure in the elderly.
1997-401AMoblleComponantof the AorticPiaqueasa
Major Risk Factor for Systemic Embolism in the
Elderly
A. Tenenbaum, C. Stroh, J. Shemesh, Z. Fisman, Z. Vered, M. Metro.
Gardiac Rehabilitation Institute and The Heart Institute, Sheba Medical
Centa< TelAviv Universi~, Te/Aviu Israel
Protruding aortic plaques (PAP) of Z4 mm in thickness were demonstrated
on transesophagial echoeardiography (TEE) as a potential sourca of embolic
events in the elderly. Whether the presence of a mobile com~nent (MC)
representa an additional risk for systemic emboliem (SE), has not been
established. During two years, 569 consecutive pts. (age range 16+33 yra)
underwent TEE; 106 (19%) were referred to evaluate recent SE: Cerebral in
97 pts. and peripheral or both in 11.
Results:
Numbsr (O/.)of pts O.R. (95% Cl)
SE group(n= 106) Non SE group(n= 461)
PAP (all tvoes) 35 (32) 13 (3) 16.5 (7,340.6)
PAP kith;ut MC 10 (9i 9 i2i 5.1 ~1,ti.3i
PAP withMC 25 (23) 4 (Ij 34.4 is.2-154.7)
Among the SE group, 49 (45%) exhibited ctyptogenic events (negative
TEE) and24(22%) had findings other than PAP.AI125pts with mobile Ieaions
in this group were older than 50 yeara, 21 (S4%)of them were above SO.The
presence of MC was ass~iated with abrupt increase in the risk of SE. Thus,
MC is a major risk factor and an important source of stroke and systemic
embolism in the elderly.
1997-621lnc~asedlntima,-Media,~hi~~n se(,~~)Ofthe
Common Carotid Artery (CCA) in Aeymptomatic
Volunteers with a Positive Exarcisa ECG
Y. Nagai, E.J. Metter, C.J. Earfey,M.K. Kemper, E.G. Lakatta, J.L. Fleg.
Gerontology Reseamh Center and Johns Hopkins Bayview Medical CenteC
Baffimore, MD, USA
A strong positive association has been reported between CCA IMT and
the presenee of symptomatic coronary heart diaease (CHD). However, it is
unclear whether asymptomatic CHD is also associated with increased IMT.
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Wehaveevaluatedthis relationshipusingB-modecarotidultraeonography.
IMTandcrosssectionalsystolicdiametarof the rightCCAweremeasured
in 290volunteers(M: 157,63.6+ 15.6,26-95, F: 133,56.2+ 16.0,26-90)
fromthe BaltimoreLongitudinalStudyof Aging.Basedon medicalhistory,
restingECGandmaximaltreadmillexerciseECG,aubjectawereclassified
Into3 groups:G-O:withnoclinicalor resf/exerciseECGevidenceof CHD(n
= 220),G-1:possibleCHD(n = 47) definedby asymptomaticiachamicST
segmentdepression> 1.0mmon exerciseECGwithoutclinicalsymptoms
andG-2:manifeatCHD(n= 23).
Ags* % Men SBP (mmHg) Diameter (mm) IMr (mm)
G-o 58& 16 50 120* 14+ 6.1 * 0.7 0.51 *0.14G-1 68+ 14 60 126 +18 6.3 *0.7
G-2
0.66+0.19
78& 7 63** 125 l17 6.34z0.7 0.69 +0.19
(“Allgroupsdifieratp=0.0000,**P c 0.01 and ‘p < 0.05vs othsrtwo groups)
Bycorrelationanalysis,IMTwaspositivelyaa-sociatadwithage(r= 0.63,
P = 0.000),systolicbloodpressure(SBP)(r = 0.27,p = 0.000)and CCA
diameter(r= O.30,P=O.000).Bymultipleregression,IMTwasbaatexplained
by age (p= 0.0000),CCAdiameter(p < 0.001),posaibleCHD(p < 0.01)
and manifestCHD(P = 0.0000)(model# = 0.57).Thus,the presenceof
possibleCHD,asevidencedbyasymptomaticexercise-inducedSTsegment
depression,is independentlyassociatedwithan increaseof CCAIMTafter
controllingfor ageandCCAdiameter.
D99763 AssociationofPissmsHomocysteineWithExtracraniaiCarotidArteriaiDiseaseinOider
Persons
W.S.Aronow,C.Ahn,M.R.Schoenfeld.h40urrtSinaiScfroolofh-fadicirre,
NewYork,NY USA,UrriversifyofTexasMedicalSchoolat Houston,
Houston,TX,USA
Ina prospectivestudy,wecorrelatadpiasmahomooysteine,vitaminBw,and
folatelevelswiththe prevalenceof40%.to 100%extrecmnialcarotidarterial
disease(ECAD)detectedbycarotidduplexultraeonogrem$in 121menand
279women,meanage61 + 8 years.Fortyto 100%ECADoccurredin 22
of 121men(18%)andin43 of 279women(15%)(p= 0.490).Meanplasma
homooysteinelevel (wmolper liter)was 19 + 6 in menwithECADversua
14 + 4 in menwithoutECAD(p = 0.003)and 17+4 in womenwithECAD
veffiue13+ 5 in womenwithoutECAD(p < 0.0001).Meanplasmavitamin
BIZ(n@parliter)wae454+ 215inmenwithECADversus553& 164in men
withoutECAD(p= 0.052)and443+ 126in womenwithECADversus533
A 157in womenwithoutECAD(p = 0.0305).Meanplasmafolatelevel(#g
per liter)was6.3 & 2.1 in menwithECADversue9.5+ 3.2 in manwithout
ECAD(p= 0.0001)and6.3+ 1.4in womenwithECADversus9.5+ 3.1 in
womenwithoutECAD(p = 0.0001).A low plasmafolatelevel(< 3 ~g par
liter)was presentin noneof 400 persons(O%).A lowplasmavitaminB12
level (c 160nglparliter)waspresentin2 of22 men(9%)withECADversus
1 of 99 men (l%) withoutECAD(p = 0.085)and in 1 of 43 women(2%)
with ECADversus1 of 236 women(c IYo) withoutECAD(p = 0.285).An
increasedplasmahomocysteinelevel(> 17wmolpar liter)occurredin 10
of 22 men(L15Yo)withECADversus20 of 99 men(20%)withoutECAD(p=
0.013)and in 17of 43 women(40%)with ECADversus43 of 236women
(16%)withoutECAD(p=0.002).Thesedatashowthatanincreasedplasma
homooysteinelevelisaasociatadwith40%to 100%ECADinoldermenand
women.
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[998-1421 HoapiteitoHospitaiTraneferofpatients
RequiringCoronaryArteryBypaasSurgery:
impactonCoetandCiinicaiOutcomea
G.L.Kay,G.-W.Sun,C.A.Prejean,M.R.Estioko,J.H.Kay.TheFfearl
Institute,GoodSamaritanHospital,LosAngeles,CA,USA
Todeterminethe influenceof trenspoti(T)on hrx.piteloutcomes,datawere
reviewedfor4367 consecutivepatientsundergoingcoronatyarterybypeea
betwwn l/1/90 and lZ3i/95. Of which,1374patients(32%)weretrans-
ported fmm anotherfacility.Comparisonsof hospitaloutcomesbetwwn
transportadpatientsand non-transpcfiadpatientswere performedualng
bothnon-parametricandmultivariateanalysis.Patientdemographics,madi-
calhistory,andproceduretypeswereusedfor riskadjustment.
Outcome T Non-T p (unadj.) p (adj.)
Mortality(%) 7.2 4.0 <0.001 0,134
Complication(%) 22.6 16.5 <0,001
LOS (d)
0.387
9.s 9.0 <0,001 0.116
Preop LOS (d) 1.4 1,4 <0.001 0.367
ICU LOS (d) 3.4 2,5 <0.001 0.006
PoatopLOS (d) 8.4 7.6 0.001 0.860
Coats ($1,000) 21.7 19,3 <0,001 0.032
Cone/usions:l)Beforeriskadjustment,transpotiedpatientshadmarkedly
worseclinicalandcostoutcomesthannon-transportedpatients.2) Afterriak
adjustment,hospitalcostsand ICUlength-of-stayare still longerfor trans-
portedpatientsthan for non-trenspotiadpatients.3) Transportadpatients
havehigherriskfactora/profilesthannon-transportedpatients.
m998143 Long-TermFoiiow-upof RheumaticPatientaUndergoingTricuspidAnnuiopiastyWith
Left-SidedVaiveReplacement
R.Tager,D.Skudicky,U.Mueller,G. Hammond,P.Sareli.Baragwanath
Hospital,Johannesburg,SouthAfrica
The long-termresultsof the modifiedDe Vegatricuspidannuloplasty(TA)
in rheumaticpatientsundergoingleft-sidedvalvereplacementareunknown.
BetweenSeptember1989and December1991,TAwae performedon 49
patients(pts)thatsurvivedsurgetyfor aortic,mitralor doublevalvereplace-
ment.Completeechooardiographicfoliow-upwasavailablein 43 pta(mean
age31 k 13years,meanfollow-up57 + 16 monthe).Atrialfibrillationwee
documentedpreoperetivelyin20/43pta.PreoperativeindicationsforTAwere
moderateor severetricuspidregurgitationin 33 ptsandmildor notricuapid
regurgitationbut a dilatedtricuspidannulua(233 mm) on 2 dimensional
echocsrdiographyat enddiastolein 10pta.Organictticuepidleafletdisease
waadocumentedin 16/43pts. Long-termmortalitywas 12% (6 pts, none
hadmorethan mild residualtricuspidregurgitationat Iateetfoilow-up).On
Dopplercolorflowmapping,postoperativeseveretricuspidregurgitationwee
presentin1ptandmoderatetricuspidregurgitationin4ptsat Iatestfollow-up.
Thetricuspidannulussizedeclinedfrom37 + 5 mmpreoperetivelyto 24 +
6 mmat latestfollow-up(p e 0.0001).Pulmonaryarterysyatolicpressure
declinedfrom53+ 21mmHgatbaselineto39+ 16mmHg(P=O.03)at latest
follow-upin the 16 pts in whompulmonarypressurecouldbe assessedby
Dopplerexaminationpre-andpostoperatively.Inconclusion:1)ModifiedDe
VegaTAiea durableprocedurein rheumaticpts.2) Itappeamthat reducing
thediastolicannularsizeto24 mmisadequateto preventresidualtricuapid
regurgitationin the long-term.
m998144 Preeswationof theSubvaivularApparatuaimprovesLongTermLeftVentricularDimensions
andPuimonaryArteryPressurein Patients
UndergoingMitraiValveRepairor Replacement
DeepiteComparableLeftVentricularEjection
Fractiona
A.’Raina,A.Chaux,V.Rurycz,H.Luo,R.J.Siegel.Cedars-SinaiMedical
CentecLosAngeles,CA,USA
Patienta(pts)havingmitralvalve(MV)repairor replacementwithpreservad
subvalvularapparatus(PSVA)do betterthanthoaewithout(W)PSVA.How-
ever, it is unknownhow these2 groupsdiffer on long term follow-up.by
Dopplerechocardiography(2De).Methods:2Dewas uaedto study67 pte
(66.2+ 15.4yrs)whohadMVrepair(n= 46) or replacementwith(n = 17)
or without(n= 24)PSVA.All ptshadpreoperative2De <1 month(M)prior
to surgaryandat follow-up12&9 montha(M)aftersurgery.Results:There
weenoaignificentchangeintheLVEFbetweenthepreopandpoatop2Deat
12+ 9 Mfollow-up.
PAP LVEDD LVESD LAs
pre poatop pra postop pre postop pre poetop
MV repair 43& 9 36+ 13* 55 &7” 51 k 7* 38+ 8 34&8* 49+7 44 *6*
MVR PSV 47 k S 35&6* 55+9 46 =t7* 33 k6 33& 9* 52 k 4 47*8*
MVR only 41 + 9 39+10 53+6 51 + 6 35*7 33* 7 52& 9 49+ S
*p< 0.01, PAP: pulmona~artery preaeure, EDD: end diastolicdimenaion,ES: end eye-
tolio,LAS: Iettatrlalsize.
Cone/uaions.’At 12 + 9 M ptswho hadPSVA,regardlessof havingMV
repairor replacement,hadimprovementin LVEDD,LVESD,IAS and PAP
(p < 0.01)whereasno improvementin theseparameterswasfoundin pts
whodid not havepreservationof the mitralsubvalvularapparatus,despite
comparableejectionfractionspre-opandpost-opin all thegroups.
